NewslettersCell Therapy NewsUncategorizedpiggyBac System to Co-Express NKG2D CAR and IL-15 to Augment the In Vivo Persistence and Anti-AML Activity of Human Peripheral Blood NK CellsBy Justin.choi - November 8, 20210129Using a non-viral piggyBac transposon technology and human peripheral blood derived primary natural killer (NK) cells, scientists generated CAR-NK cells to target NKG2D ligands.[Molecular Therapy-Methods & Clinical Development] 6445212 AAAAAAAA items 1 apa 0 default asc 1 168661 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/AbstractFull ArticleGraphical Abstract